Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 13/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | ITK | Q08881 | 1/20 | 0.41 |
| ▸ | RHOA | P61586 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22356460 | 1.00 | SYK (0.47) | SYKCYP3A4KCNH3ALDH1A1CYP1A2 | |
| SCHEMBL22356447 | 0.96 | RHOA (0.47) | SYKCYP3A4KCNH3EGFRITK | |
| SCHEMBL22356454 | 0.94 | KCNH3 (0.47) | SYKCYP3A4KCNH3ALDH1A1EGFR | |
| SCHEMBL22356492 | 0.92 | KCNH3 (0.46) | SYKKCNH3EGFRITKRHOA | |
| SCHEMBL22356452 | 0.90 | RHOA (0.52) | KCNH3ALDH1A1CYP1A2EGFRITK | |
| SCHEMBL22356351 | 0.90 | RHOA (0.52) | KCNH3ALDH1A1CYP1A2EGFRITK | |
| SCHEMBL22356390 | 0.89 | RHOA (0.51) | KCNH3ALDH1A1EGFRITKRHOA | |
| SCHEMBL22356437 | 0.89 | RHOA (0.51) | KCNH3ALDH1A1EGFRITKRHOA | |
| SCHEMBL22356430 | 0.85 | MTNR1B (0.51) | KCNH3APPAURKA | |
| SCHEMBL22356477 | 0.84 | EGFR (0.43) | SYKKCNH3EGFRITK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TREEEL CO., LTD (KR) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TYR, CRY2, CRY1 | SYK 1816/4885CYP3A4 322/4885KCNH3 563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.